Moreover, Shlush LI et al. [36] showed that approximately 25% of adult AML patients carried the DNMT3A mutation in pre-leukemia HSCs and that the mutation could enhance pre-leukemia HSC proliferation, which probably accounted for the clonal expansion of the pre-leukemia HSCs identified at diagnosis. This evidence concerns the gene DNMT3A and acute myeloid leukemia.